Conformational changes of G protein-coupled receptors during their activation by agonist binding.
The superfamily of G protein-coupled receptors (GPCRs) is the largest and most diverse group of transmembrane proteins involved in signal transduction. Many of the over 1000 human GPCRs represent important pharmaceutical targets. However, despite high interest in this receptor family, no high-resolution structure of a human GPCR has been resolved yet. This is mainly due to difficulties in obtaining large quantities of pure and active protein. Until now, only a high-resolution x-ray structure of an inactive state of bovine rhodopsin is available. Since no structure of an active state has been solved, information of the GPCR activation process can be gained only by biophysical techniques. In this review, we first describe what is known about the ground state of GPCRs to then address questions about the nature of the conformational changes taking place during receptor activation and the mechanism controlling the transition from the resting to the active state. Finally, we will also address the question to what extent information about the three-dimensional GPCR structure can be included into pharmaceutical drug design programs.
Bissantz
Caterina
C
Molecular Structure and Design, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland. caterina.bissantz@roche.com
D000818:Animals; D001665:Binding Sites; D019281:Dimerization; D015195:Drug Design; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D015394:Molecular Structure; D011485:Protein Binding; D011487:Protein Conformation; D017510:Protein Folding; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000145:classification / Q000378:metabolism*; D012243:Rhodopsin / Q000737:chemistry / Q000378:metabolism
D008024:Ligands; D043562:Receptors, G-Protein-Coupled; D012243:Rhodopsin